{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:00:16Z","timestamp":1792598416409,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["016 VENI 178.064"],"award-info":[{"award-number":["016 VENI 178.064"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jhepr.2024.101103","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T21:28:26Z","timestamp":1714166906000},"page":"101103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The potential of volatile organic compounds to diagnose primary sclerosing cholangitis"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1953-0207","authenticated-orcid":false,"given":"Robert","family":"van Vorstenbosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"van Munster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Stavropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle","family":"Pachen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik-Jan","family":"van Schooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5203-0453","authenticated-orcid":false,"given":"Cyriel","family":"Ponsioen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Smolinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jhepr.2024.101103_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/bmb\/ldv019","article-title":"Primary sclerosing cholangitis: a clinical update","volume":"114","author":"Williamson","year":"2015","journal-title":"Br Med Bull"},{"issue":"2","key":"10.1016\/j.jhepr.2024.101103_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1586\/egh.12.80","article-title":"Primary sclerosing cholangitis: a review and update on therapeutic developments","volume":"7","author":"Tabibian","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2024.101103_bib3","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"49","author":"Steenstraten","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jhepr.2024.101103_bib4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4254\/wjh.v6.i4.178","article-title":"Update on inflammatory bowel disease in patients with primary sclerosing cholangitis","volume":"6","author":"Tsaitas","year":"2014","journal-title":"World J Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2024.101103_bib5","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101103_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/CEG.S105872","article-title":"Primary sclerosing cholangitis: diagnostic and management challenges","volume":"10","author":"Sirpal","year":"2017","journal-title":"Clin Exp Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhepr.2024.101103_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5009\/gnl16510","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features","volume":"12","author":"Palmela","year":"2018","journal-title":"Gut and liver"},{"issue":"1","key":"10.1016\/j.jhepr.2024.101103_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jhepr.2024.101103_bib9","article-title":"Implementation of quality controls is essential to prevent batch effects in breathomics data and allow for cross-study comparisons","volume":"14","author":"Stavropoulos","year":"2020","journal-title":"J\u00a0Breath Res"},{"issue":"8","key":"10.1016\/j.jhepr.2024.101103_bib10","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1097\/MIB.0000000000000436","article-title":"Volatile organic compounds in exhaled air as novel marker for disease activity in crohn's disease: a metabolomic approach","volume":"21","author":"Bodelier","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.jhepr.2024.101103_bib11","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1111\/liv.14645","article-title":"Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis","volume":"40","author":"Culver","year":"2020","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.jhepr.2024.101103_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1148\/radiol.10091953","article-title":"Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography","volume":"256","author":"Dave","year":"2010","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.jhepr.2024.101103_bib13","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/apt.14004","article-title":"The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis","volume":"45","author":"Smolinska","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.jhepr.2024.101103_bib14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3390\/metabo11090618","article-title":"Liver impairment\u2014the potential application of volatile organic compounds in hepatology","volume":"11","author":"Stavropoulos","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.jhepr.2024.101103_bib15","series-title":"Breathborne biomarkers and the human volatilome","author":"Beauchamp","year":"2020"},{"issue":"3","key":"10.1016\/j.jhepr.2024.101103_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41575-022-00690-y","article-title":"The microbiota and the gut-liver axis in primary sclerosing cholangitis","volume":"20","author":"Hov","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2024.101103_bib17","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.gie.2014.09.041","article-title":"Volatile organic compounds in bile for early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis: a pilot study","volume":"81","author":"Navaneethan","year":"2015","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"10.1016\/j.jhepr.2024.101103_bib18","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1007\/s10620-015-3596-x","article-title":"Volatile organic compounds in urine for noninvasive diagnosis of malignant biliary strictures: a pilot study","volume":"60","author":"Navaneethan","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.jhepr.2024.101103_bib19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/liv.15471","article-title":"Disease burden in primary sclerosing cholangitis in The Netherlands: a long-term follow-up study","volume":"43","author":"van Munster","year":"2023","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.jhepr.2024.101103_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2024.101103_bib21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders","volume":"11","author":"Magro","year":"2017","journal-title":"J\u00a0Crohn's Colitis"},{"issue":"1","key":"10.1016\/j.jhepr.2024.101103_bib22","article-title":"Optimisation of sampling parameters for standardised exhaled breath sampling","volume":"12","author":"Doran","year":"2017","journal-title":"J\u00a0breath Res"},{"issue":"1","key":"10.1016\/j.jhepr.2024.101103_bib23","article-title":"The necessity of external validation in exhaled breath research: a case study of sarcoidosis","volume":"12","author":"Fijten","year":"2017","journal-title":"J\u00a0Breath Res"},{"issue":"11","key":"10.1016\/j.jhepr.2024.101103_bib24","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1111\/liv.14644","article-title":"The Simple Cholestatic Complaints Score is a valid and quick patient-reported outcome measure in primary sclerosing cholangitis","volume":"40","author":"van Munster","year":"2020","journal-title":"Liver Int"},{"issue":"11","key":"10.1016\/j.jhepr.2024.101103_bib25","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.crohns.2012.11.007","article-title":"The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers","volume":"7","author":"Bennebroek Evertsz","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"issue":"10","key":"10.1016\/j.jhepr.2024.101103_bib26","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/MCG.0b013e31828b2196","article-title":"Development of the patient Harvey Bradshaw index and a comparison with a clinician-based Harvey Bradshaw index assessment of Crohn's disease activity","volume":"47","author":"Bennebroek Evertsz","year":"2013","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhepr.2024.101103_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101775","article-title":"Non-invasive diagnosis and follow-up of primary sclerosing cholangitis","volume":"46","author":"Chazouill\u00e8res","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhepr.2024.101103_bib28","series-title":"Breathborne biomarkers and the human volatilome","first-page":"633","article-title":"Preprocessing and analysis of volatilome data","author":"Stavropoulos","year":"2020"},{"issue":"5","key":"10.1016\/j.jhepr.2024.101103_bib29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/cem.2790","article-title":"Unsupervised random forest: a tutorial with case studies","volume":"30","author":"Afanador","year":"2016","journal-title":"J\u00a0Chemometrics"},{"key":"10.1016\/j.jhepr.2024.101103_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forest","volume":"45","author":"Breiman","year":"2001","journal-title":"Machine Learn"},{"issue":"1","key":"10.1016\/j.jhepr.2024.101103_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/00401706.1969.10490666","article-title":"Computer aided design of experiments","volume":"11","author":"Kennard","year":"1969","journal-title":"Technometrics"},{"key":"10.1016\/j.jhepr.2024.101103_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.339001","article-title":"Advanced data fusion: random forest proximities and pseudo-sample principle towards increased prediction accuracy and variable interpretation","author":"Stavropoulos","year":"2021","journal-title":"Analytica Chim Acta"},{"key":"10.1016\/j.jhepr.2024.101103_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aca.2015.06.042","article-title":"Regularized MANOVA (rMANOVA) in untargeted metabolomics","volume":"899","author":"Engel","year":"2015","journal-title":"Analytica Chim Acta"},{"issue":"11","key":"10.1016\/j.jhepr.2024.101103_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9111563","article-title":"Breath-taking perspectives and preliminary data toward early detection of chronic liver diseases","volume":"9","author":"Murgia","year":"2021","journal-title":"Biomedicines"},{"issue":"9930","key":"10.1016\/j.jhepr.2024.101103_bib35","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jhepr.2024.101103_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e05922","article-title":"Deficiency and absence of endogenous isoprene in adults, disqualified its putative origin","volume":"7","author":"Sukul","year":"2021","journal-title":"Heliyon"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924001071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924001071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:08:14Z","timestamp":1778904494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555924001071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2589555924001071"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101103","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential of volatile organic compounds to diagnose primary sclerosing cholangitis","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101103"}}